Oncology: GI

You have access
⁶⁸Ga-DOTA-FAPI-04 PET/MR in the evaluation of gastric carcinomas: comparison with ¹⁸F-FDG PET/CT
Chunxia Qin, Fuqiang Shao, Yongkang Gai, Qingyao Liu, Weiwei Ruan, Fang Liu, Fan Hu and Xiaoli Lan

Journal of Nuclear Medicine April 16, 2021, jnumed.120.258467; DOI: https://doi.org/10.2967/jnumed.120.258467
You have access
Dose-response and dose-toxicity relationships for yttrium-90 glass radioembolization in patients with colorectal cancer liver metastases
Ahmed A. Alsultan, Caren van Roekel, Maarten W. Barentsz, Maarten L. J. Smits, Britt Kunnen, Miriam Koopman, Rutger C.G. Bruijnen, Bart de Keizer and Marnix G.E.H. Lam

Journal of Nuclear Medicine March 19, 2021, jnumed.120.255745; DOI: https://doi.org/10.2967/jnumed.120.255745
You have access
Bowel Obstruction as a Complication of Peptide Receptor Radionuclide Therapy (PRRT)
Christopher E Wee, Ayca Dundar, Rachel A Eiring, Mohamed Badawy, Timothy J Hobday, Ayse Tuba Kendi, Annie T Packard and Thorvardur R. Halfdanarson

Journal of Nuclear Medicine March 19, 2021, jnumed.121.262048; DOI: https://doi.org/10.2967/jnumed.121.262048
You have access
Quantitative ⁶⁸Ga-DOTATATE PET/CT parameters for the prediction of therapy response in patients with progressive metastatic neuroendocrine tumors treated with ¹⁷⁷Lu-DOTATATE
Claudia Ortega, Rebecca KS Wong, Joshua Schaefferkoetter, Patrick Veit-Haibach, Sten Myrehaug, Rosalyn Juergens, David Laidley, Reut Anconina, Zhihui Amy Liu and Ur Metser

Journal of Nuclear Medicine February 12, 2021, jnumed.120.256727; DOI: https://doi.org/10.2967/jnumed.120.256727
You have access
Utility of ²¹¹At-trastuzumab for the Treatment of Metastatic Gastric Cancer in the Liver: Evaluation of a Preclinical α-Radioimmunotherapy Approach in a Clinically-relevant Mouse Model
Huizi Keiko Li, Yukie Morokoshi, Satoshi Kodaira, Tamon Kusumoto, Katsuyuki Minegishi, Hiroaki Kanda, Kotaro Nagatsu and SUMITAKA HASEGAWA

Journal of Nuclear Medicine February 5, 2021, jnumed.120.249300; DOI: https://doi.org/10.2967/jnumed.120.249300
Open Access
Addition Of ¹³¹I MIBG To PRRT (⁹⁰Y DOTATOC) For Personalized Treatment of Selected Patients with Neuroendocrine Tumors
David L. Bushnell, Kellie L. Bodeker, Thomas M. O'Dorisio, Mark T. Madsen, Yusuf Menda, Stephen A Graves, M. Sue O'Dorisio and Gideon K. D. Zamba

Journal of Nuclear Medicine January 30, 2021, jnumed.120.254987; DOI: https://doi.org/10.2967/jnumed.120.254987

Main menu

User menu

Search

Oncology: GI